{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:08:39Z","timestamp":1792202919388,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jid.2017.01.031","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T15:30:26Z","timestamp":1486999826000},"page":"1240-1247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":186,"title":["The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis\u00a0in the UK"],"prefix":"10.1016","volume":"137","author":[{"given":"Noel","family":"Frey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Jossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bodmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Jick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph R.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Spoendlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2017.01.031_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1528-1157.1995.tb01005.x","article-title":"Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984","volume":"36","author":"Annegers","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.jid.2017.01.031_bib2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1592\/phco.31.9.925","article-title":"Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma","volume":"31","author":"Boruah","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jid.2017.01.031_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PEC.0000000000000195","article-title":"Tumor lysis syndrome: risk factors, diagnosis, and management","volume":"30","author":"Burns","year":"2014","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.jid.2017.01.031_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jaad.2014.06.026","article-title":"Mycoplasma pneumoniae\u2013induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: A systematic review","volume":"72","author":"Canavan","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2017.01.031_bib5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical\u00a0genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jid.2017.01.031_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/pds.3937","article-title":"Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry","volume":"25","author":"Diphoorn","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jid.2017.01.031_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lungcan.2016.02.015","article-title":"Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient","volume":"95","author":"Doesch","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jid.2017.01.031_bib8","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2165\/00003495-200767090-00003","article-title":"Antiepileptic drugs in the treatment of neuropathic pain","volume":"67","author":"Eisenberg","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.jid.2017.01.031_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/pds.4124","article-title":"Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink","volume":"26","author":"Frey","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jid.2017.01.031_bib10","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/CCM.0b013e31821201ed","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review","volume":"39","author":"Gerull","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jid.2017.01.031_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000335627","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"97","author":"Harr","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.jid.2017.01.031_bib12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jid.2017.01.031_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","article-title":"Validation and validity of diagnoses in the General Practice Research Database: a systematic review","volume":"69","author":"Herrett","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jid.2017.01.031_bib14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2340\/00015555-2027","article-title":"Stevens-Johnson syndrome associated with mogamulizumab-induced deficiency of regulatory T cells in an adult T-cell leukaemia patient","volume":"95","author":"Honda","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2017.01.031_bib15","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jid.2016.03.023","article-title":"Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States Adults","volume":"136","author":"Hsu","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.01.031_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1159\/000351918","article-title":"Stevens-Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma","volume":"91","author":"Ikeda","year":"2013","journal-title":"Urol Int"},{"key":"10.1016\/j.jid.2017.01.031_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.leukres.2012.03.006","article-title":"Stevens-Johnson syndrome after treatment with bendamustine","volume":"36","author":"Lambertini","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.jid.2017.01.031_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ageing\/29.1.35","article-title":"Contribution of adverse drug reactions to hospital admission of older patients","volume":"29","author":"Mannesse","year":"2000","journal-title":"Age Ageing"},{"key":"10.1016\/j.jid.2017.01.031_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.01.031_bib20","unstructured":"Office for National Statistics UK. Statistical bulletin: births in England and Wales: 2013, https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/livebirths\/bulletins\/birthsummarytablesenglandandwales\/2014-07-16; 2014 (accessed 27 February 2017)."},{"issue":"24","key":"10.1016\/j.jid.2017.01.031_bib21","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2017.01.031_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2133.1996.tb03598.x","article-title":"Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"135","author":"Rzany","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2017.01.031_bib23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jid.2017.01.031_bib24","unstructured":"Squires DA. The U.S. health system in perspective: a comparison of twelve industrialized nations, http:\/\/www.commonwealthfund.org\/\u223c\/media\/Files\/Publications\/Issue Brief\/2011\/Jul\/1532_Squires_US_hlt_sys_comparison_12_nations_intl_brief_v2.pdf; 2011 (accessed 1 October 2016)."},{"key":"10.1016\/j.jid.2017.01.031_bib25","unstructured":"The Joint Epilepsy Council of the UK and Ireland. Joint Epilepsy Council prevalence and incidence, www.epilepsyscotland.org.uk\/pdf\/Joint_Epilepsy_Council_Prevalence:and_Incidence:September_11_(3).pdf; 2011 (accessed 27 February 2017)."},{"key":"10.1016\/j.jid.2017.01.031_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaad.2011.10.012","article-title":"Erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis associated with lupus erythematosus","volume":"67","author":"Torchia","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2017.01.031_bib27","unstructured":"UK Antibiotic Research. New research reveals that antibiotic prescriptions are rising in the most deprived areas of England. 2015. Available from: http:\/\/www.antibioticresearch.org.uk\/wp-content\/uploads\/2015\/11\/EXASOL-Analyses_Antibiotic-Research-UK-Final-121115.pdf; 2015 (accessed 27 February 2017)."},{"key":"10.1016\/j.jid.2017.01.031_bib28","unstructured":"UK MHRA. Prescribing trends for SSRIs and related antidepressants, http:\/\/webarchive.nationalarchives.gov.uk\/20141205150130\/http:\/\/www.mhra.gov.uk\/home\/groups\/pl-p\/documents\/websiteresources\/con019473.pdf; 2004 (accessed 27 February 2017)."},{"key":"10.1016\/j.jid.2017.01.031_bib29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1365-4632.2011.05356.x","article-title":"Stevens-Johnson syndrome\u00a0and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer","volume":"51","author":"Urosevic-Maiwald","year":"2012","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.jid.2017.01.031_bib30","doi-asserted-by":"crossref","first-page":"e0165933","DOI":"10.1371\/journal.pone.0165933","article-title":"Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using national health insurance Ddatabase in Korea","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2017.01.031_bib31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2133.2011.10705.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature","volume":"166","author":"Ziemer","year":"2012","journal-title":"Br J Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17301768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17301768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T08:52:27Z","timestamp":1542963147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X17301768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0022202X17301768"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2017.01.031","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis\u00a0in the UK","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2017.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}